866-997-4948(US-Canada Toll Free)

China Cancer Monoclonal Antibodies Market Research Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Cancer

No. of Pages : 108 Pages

Notes:
Sales, means the sales volume of Cancer Monoclonal Antibodies
Revenue, means the sales value of Cancer Monoclonal Antibodies

This report studies Cancer Monoclonal Antibodies in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
F. Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Takeda Pharmaceuticals
AstraZeneca
Bayer
Merck
Janssen Biotech
Novartis
OncoMed Pharmaceuticals
Pfizer
Eli Lilly
Sanofi
TG Therapeutics
CTI BioPharma
Intas Pharmaceuticals
Boehringer Ingelheim
Biogen

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Naked MAbs
Conjugated MAbs
Split by Application, this report focuses on consumption, market share and growth rate of Cancer Monoclonal Antibodies in each application, can be divided into
Immune System Suppressors
Kill or Inhibit Malignant Cells
Deliver Chemotherapy To Cancer Cells

Table of Contents

China Cancer Monoclonal Antibodies Market Research Report 2017
1 Cancer Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Cancer Monoclonal Antibodies
1.2 Cancer Monoclonal Antibodies Segment by Type
1.2.1 China Production Market Share of Cancer Monoclonal Antibodies Type in 2015
1.2.2 Naked MAbs
1.2.3 Conjugated MAbs
1.3 Applications of Cancer Monoclonal Antibodies
1.3.1 Cancer Monoclonal Antibodies Consumption Market Share by Application in 2015
1.3.2 Immune System Suppressors
1.3.3 Kill or Inhibit Malignant Cells
1.3.4 Deliver Chemotherapy To Cancer Cells
1.4 China Market Size (Value) of Cancer Monoclonal Antibodies (2012-2022)
1.5 China Cancer Monoclonal Antibodies Status and Outlook
1.6 Government Policies

2 China Cancer Monoclonal Antibodies Market Competition by Manufacturers
2.1 China Cancer Monoclonal Antibodies Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Cancer Monoclonal Antibodies Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Cancer Monoclonal Antibodies Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Cancer Monoclonal Antibodies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Cancer Monoclonal Antibodies Market Concentration Rate
2.5.2 Cancer Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers

3 China Cancer Monoclonal Antibodies Manufacturers Profiles/Analysis
3.1 F. Hoffmann-La Roche
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Amgen
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Amgen Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Bristol-Myers Squibb
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Bristol-Myers Squibb Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Takeda Pharmaceuticals
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 AstraZeneca
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 AstraZeneca Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Bayer
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Bayer Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Merck
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Merck Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Janssen Biotech
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Janssen Biotech Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Novartis
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Novartis Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 OncoMed Pharmaceuticals
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Pfizer
3.12 Eli Lilly
3.13 Sanofi
3.14 TG Therapeutics
3.15 CTI BioPharma
3.16 Intas Pharmaceuticals
3.17 Boehringer Ingelheim
3.18 Biogen

4 China Cancer Monoclonal Antibodies Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Cancer Monoclonal Antibodies Capacity, Production and Growth (2012-2017)
4.2 China Cancer Monoclonal Antibodies Revenue and Growth (2012-2017)
4.3 China Cancer Monoclonal Antibodies Production, Consumption, Export and Import (2012-2017)

5 China Cancer Monoclonal Antibodies Production, Revenue (Value), Price Trend by Type
5.1 China Cancer Monoclonal Antibodies Production and Market Share by Type (2012-2017)
5.2 China Cancer Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
5.3 China Cancer Monoclonal Antibodies Price by Type (2012-2017)
5.4 China Cancer Monoclonal Antibodies Production Growth by Type (2012-2017)

6 China Cancer Monoclonal Antibodies Market Analysis by Application
6.1 China Cancer Monoclonal Antibodies Consumption and Market Share by Application (2012-2017)
6.2 China Cancer Monoclonal Antibodies Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaCancer Monoclonal Antibodies Market Analysis by Regions (Provinces)
7.1 China Cancer Monoclonal Antibodies Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Cancer Monoclonal Antibodies Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Cancer Monoclonal Antibodies Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Cancer Monoclonal Antibodies Sales Price by Regions (Provinces)(2012-2017)
7.2 China Cancer Monoclonal Antibodies Consumption by Regions (Provinces)(2012-2017)
7.3 China Cancer Monoclonal Antibodies Production, Consumption, Export and Import (2012-2017)

8 Cancer Monoclonal Antibodies Manufacturing Cost Analysis
8.1 Cancer Monoclonal Antibodies Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Monoclonal Antibodies

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Cancer Monoclonal Antibodies Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Cancer Monoclonal Antibodies Market Forecast (2017-2022)
12.1 China Cancer Monoclonal Antibodies Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Cancer Monoclonal Antibodies Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Cancer Monoclonal Antibodies Production Forecast by Type (2017-2022)
12.4 China Cancer Monoclonal Antibodies Consumption Forecast by Application (2017-2022)
12.5 China Cancer Monoclonal Antibodies Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Cancer Monoclonal Antibodies Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Cancer Monoclonal Antibodies Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Cancer Monoclonal Antibodies Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Cancer Monoclonal Antibodies Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Cancer Monoclonal Antibodies
Figure China Production Market Share of Cancer Monoclonal Antibodies by Type in 2015
Figure Product Picture of Naked MAbs
Table Major Manufacturers of Naked MAbs
Figure Product Picture of Conjugated MAbs
Table Major Manufacturers of Conjugated MAbs
Table Cancer Monoclonal Antibodies Consumption Market Share by Application in 2015
Figure Immune System Suppressors Examples
Figure Kill or Inhibit Malignant Cells Examples
Figure Deliver Chemotherapy To Cancer Cells Examples
Figure China Cancer Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Table China Cancer Monoclonal Antibodies Capacity of Key Manufacturers (2015 and 2016)
Table China Cancer Monoclonal Antibodies Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Cancer Monoclonal Antibodies Capacity of Key Manufacturers in 2015
Figure China Cancer Monoclonal Antibodies Capacity of Key Manufacturers in 2016
Table China Cancer Monoclonal Antibodies Production of Key Manufacturers (2015 and 2016)
Table China Cancer Monoclonal Antibodies Production Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Monoclonal Antibodies Production Share by Manufacturers
Figure 2016 Cancer Monoclonal Antibodies Production Share by Manufacturers
Table China Cancer Monoclonal Antibodies Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Cancer Monoclonal Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Cancer Monoclonal Antibodies Revenue Share by Manufacturers
Table 2016 China Cancer Monoclonal Antibodies Revenue Share by Manufacturers
Table China Market Cancer Monoclonal Antibodies Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Cancer Monoclonal Antibodies Average Price of Key Manufacturers in 2015
Table Manufacturers Cancer Monoclonal Antibodies Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Monoclonal Antibodies Product Type
Figure Cancer Monoclonal Antibodies Market Share of Top 3 Manufacturers
Figure Cancer Monoclonal Antibodies Market Share of Top 5 Manufacturers
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Cancer Monoclonal Antibodies Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Monoclonal Antibodies Market Share (2012-2017)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Cancer Monoclonal Antibodies Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Cancer Monoclonal Antibodies Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Cancer Monoclonal Antibodies Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Cancer Monoclonal Antibodies Market Share (2012-2017)
Table Janssen Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Biotech Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Biotech Cancer Monoclonal Antibodies Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Cancer Monoclonal Antibodies Market Share (2012-2017)
Table OncoMed Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TG Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CTI BioPharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Cancer Monoclonal Antibodies Capacity, Production and Growth (2012-2017)
Figure China Cancer Monoclonal Antibodies Revenue (Million USD) and Growth (2012-2017)
Table China Cancer Monoclonal Antibodies Production, Consumption, Export and Import (2012-2017)
Table China Cancer Monoclonal Antibodies Production by Type (2012-2017)
Table China Cancer Monoclonal Antibodies Production Share by Type (2012-2017)
Figure Production Market Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Figure 2015 Production Market Share of Cancer Monoclonal Antibodies by Type
Table China Cancer Monoclonal Antibodies Revenue by Type (2012-2017)
Table China Cancer Monoclonal Antibodies Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Figure 2015 Revenue Market Share of Cancer Monoclonal Antibodies by Type
Table China Cancer Monoclonal Antibodies Price by Type (2012-2017)
Figure China Cancer Monoclonal Antibodies Production Growth by Type (2012-2017)
Table China Cancer Monoclonal Antibodies Consumption by Application (2012-2017)
Table China Cancer Monoclonal Antibodies Consumption Market Share by Application (2012-2017)
Figure China Cancer Monoclonal Antibodies Consumption Market Share by Application in 2015
Table China Cancer Monoclonal Antibodies Consumption Growth Rate by Application (2012-2017)
Figure China Cancer Monoclonal Antibodies Consumption Growth Rate by Application (2012-2017)
Table China Cancer Monoclonal Antibodies Production by Regions (Provinces)(2012-2017)
Table China Cancer Monoclonal Antibodies Production Market Share by Regions (Provinces)(2012-2017)
Table China Cancer Monoclonal Antibodies Production Value by Regions (Provinces)(2012-2017)
Table China Cancer Monoclonal Antibodies Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Cancer Monoclonal Antibodies Sales Price by Regions (Provinces)(2012-2017)
Table China Cancer Monoclonal Antibodies Consumption by Regions (Provinces)(2012-2017)
Table China Cancer Monoclonal Antibodies Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Cancer Monoclonal Antibodies Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Monoclonal Antibodies
Figure Manufacturing Process Analysis of Cancer Monoclonal Antibodies
Figure Cancer Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2015
Table Major Buyers of Cancer Monoclonal Antibodies
Table Distributors/Traders List
Figure China Cancer Monoclonal Antibodies Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Table China Cancer Monoclonal Antibodies Production, Import, Export and Consumption Forecast (2017-2022)
Table China Cancer Monoclonal Antibodies Production Forecast by Type (2017-2022)
Table China Cancer Monoclonal Antibodies Consumption Forecast by Application (2017-2022)
Table China Cancer Monoclonal Antibodies Production Forecast by Regions (Provinces)(2017-2022)
Table China Cancer Monoclonal Antibodies Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Cancer Monoclonal Antibodies Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *